
Researchers using a virus to deliver corrective genes to malfunctioning cone cells have cured a common form of blindness in mice. Excitingly, the mice retained their newfound sight -- which tests suggested was fully normal -- for months after the treatment.
As always, it's a long ways from mice to people, but some research does make that journey, and the genetic defect underlying achromotopsia -- the type of blindness studied -- is the same in humans and mice.
The therapy was made possible in part by the discovery several years ago at the Jackson Labs of mice with achromatopsia. I spoke to a Jackson lab official on the way to the Biotechnology
Industry Conference, and with several lab scientists yesterday, and they talked about a boom over the last few years in mice bred for specific genetic conditions. Granted, it's their job to be excited about that, but it sounds like a great many studies like this will soon be possible.
Related Wired coverage here and here.
Maine mice play role in eye disease cure [Boston Globe]
*
Image: _cr_*